Hostname: page-component-6bf8c574d5-9nwgx Total loading time: 0 Render date: 2025-02-24T08:31:15.732Z Has data issue: false hasContentIssue false
  • English
  • Français

A New Therapeutic Target for the Treatment of Multiple Sclerosis

Published online by Cambridge University Press:  02 December 2014

Michael O. Poulter
Michael O. Poulter*
Affiliation:
Molecular Brain Research Group, Robarts Research Institute, Dept of Physiology & Pharmacology, Faculty of Medicine, University of Western Ontario, London, Ontario, Canada
*
Molecular Brain Research Group, Robarts Research Institute, Dept of Physiology & Pharmacology, Faculty of Medicine, University of Western Ontario, 100 Perth Drive, London, Ontario, n6a 5K8, Canada. email: mpoulter@robarts.ca
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Translational Neuroscience
Information
Canadian Journal of Neurological Sciences , Volume 39 , Issue 5 , September 2012 , pp. 570
Copyright
Copyright © The Canadian Journal of Neurological 2012

References

1.Dann, A, Poeck, H, Croxford, AL, et al.Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS. Nat Neurosci. 2011;15:98–106.Google Scholar